Picton Mahoney Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Picton Mahoney Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$73K	–	355
2016 Q2	$73K	Hold	500	–	–	﹤0.01%	292
2016 Q1	$72K	Hold	500	–	–	﹤0.01%	289
2015 Q4	$77K	Hold	500	–	–	﹤0.01%	285
2015 Q3	$71K	Hold	500	–	–	﹤0.01%	271
2015 Q2	$72K	Hold	500	–	–	﹤0.01%	278
2015 Q1	$71K	Buy	500 +100	+25%	+$15.4K	﹤0.01%	273
2014 Q4	$59K	Buy	+400	New	+$58.8K	﹤0.01%	265

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Picton Mahoney Asset Management's TARO Position: Q3 2016 in Review

Picton Mahoney Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2016, closing a stake of 500 shares — an estimated $73K sold.

Picton Mahoney Asset Management first reported a position in TARO in Q4 2014 and held it in 7 quarters. The position peaked at $77K in Q4 2015. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

Picton Mahoney Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2016 after selling out during the quarter.
Picton Mahoney Asset Management sold 500 Taro Pharmaceutical Industries Ltd. shares in Q3 2016, an estimated $73K.
Picton Mahoney Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 7 quarters.
Picton Mahoney Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $77K in Q4 2015.
162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.